z-logo
open-access-imgOpen Access
Evolution of Hematology Clinical Trial Adverse Event Reporting to Improve Care Delivery
Author(s) -
Tamara P. Miller,
Richard Aplenc
Publication year - 2021
Publication title -
current hematologic malignancy reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.299
H-Index - 35
eISSN - 1558-822X
pISSN - 1558-8211
DOI - 10.1007/s11899-021-00627-3
Subject(s) - adverse effect , medicine , clinical trial , intensive care medicine , hematology
Reporting of adverse events on hematology clinical trials is crucial to understanding the safety of standard treatments and novel agents. However, despite the importance of understanding toxicities, challenges in capturing and reporting accurate adverse event data exist.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here